Delivers Record Q1 Net Sales Growth of 21%, Led by Volume Growth
Exceeds
First Quarter 2026 Highlights
-
Net sales grew 21.2% year over year to
$46.1 million - Gross profit margin was 48.4%, a reduction of 1.7 percentage points year over year
-
Net loss was
$2.4 million , or$0.03 per share to Zevia’s Class A Common stockholders, including$0.9 million of non-cash equity-based compensation expense, an improvement of$4.0 million year over year -
Adjusted net loss was
$0.1 million (1) -
Adjusted EBITDA was
$0.9 million (1), an improvement of$4.2 million year over year
“We’re off to a strong start to the year, delivering record sales growth and positive adjusted EBITDA, both of which exceeded our expectations. These results clearly demonstrate the strong progress we are making against our strategic growth pillars," said
First Quarter 2026 Results
Net sales improved 21.2% to
Gross profit margin was 48.4% in the first quarter of 2026 compared to 50.1% in the first quarter of 2025, a reduction of 1.7 percentage points. The reduction was primarily due to higher aluminum costs.
Selling and marketing expenses were
Marketing expenses were
(1) Adjusted Net Loss and Adjusted EBITDA are non-GAAP financial measures. See the supplementary schedules in this press release for a discussion of how we define and calculate these measures and a reconciliation thereof to the most directly comparable GAAP measures.
General and administrative expenses were
Equity-based compensation, a non-cash expense, was
Restructuring expenses were
Net loss in the first quarter of 2026 was
Loss per share in the first quarter of 2026 was
Adjusted net loss in the first quarter of 2026 was
Adjusted EBITDA was
Adjusted net loss and Adjusted EBITDA are non-GAAP financial measures. See the supplementary schedules in this press release for a discussion of how we define and calculate these measures and a reconciliation thereof to the most directly comparable GAAP measure.
Balance Sheet and Cash Flows
As of
2026 Outlook
“Our first quarter performance reflects the strong execution of our Productivity Initiative that enabled investment into our strategic growth pillars,” said
For the full year 2026, the Company now expects net sales to be in the range of
For the second quarter of 2026, the Company expects net sales to be in the range of
We have not provided the forward-looking GAAP equivalent to our Adjusted EBITDA outlook or a GAAP reconciliation as a result of the uncertainty regarding, and the potential variability of, reconciling items such as stock-based compensation, income tax, certain litigation expenses, and charges associated with restructuring and cost saving initiatives, including but not limited to severance costs, warehouse/distribution facility exit costs, and asset impairments. Accordingly, a reconciliation of this non-GAAP guidance metric to its corresponding GAAP equivalent is not available without unreasonable effort. These items are inherently variable and uncertain and depend on various factors, some of which are outside of the Company’s control or ability to predict. However, it is important to note that the reconciling items could have a significant effect on future GAAP results. We have provided historical reconciliations of GAAP to non-GAAP metrics in tables at the end of this release. For more information regarding the non-GAAP financial measures discussed in this earnings release, please see “Reconciliation of GAAP to non-GAAP Financial Results” below.
Webcast
The Company will also host a conference call to discuss its results at
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the
About Zevia
(ZEVIA-F)
|
|
|||||||
|
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) |
|||||||
|
(in thousands, except share and per share amounts) |
|||||||
|
|
Three Months Ended |
|
|||||
|
|
2026 |
|
|
2025 |
|
||
|
Net sales |
$ |
46,090 |
|
|
$ |
38,023 |
|
|
Cost of goods sold |
|
23,801 |
|
|
|
18,988 |
|
|
Gross profit |
|
22,289 |
|
|
|
19,035 |
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
Selling and marketing |
|
14,534 |
|
|
|
15,323 |
|
|
General and administrative |
|
9,066 |
|
|
|
6,978 |
|
|
Equity-based compensation |
|
894 |
|
|
|
731 |
|
|
Depreciation and amortization |
|
168 |
|
|
|
252 |
|
|
Restructuring |
|
— |
|
|
|
2,138 |
|
|
Total operating expenses |
|
24,662 |
|
|
|
25,422 |
|
|
Loss from operations |
|
(2,373 |
) |
|
|
(6,387 |
) |
|
Other income, net |
|
47 |
|
|
|
57 |
|
|
Loss before income taxes |
|
(2,326 |
) |
|
|
(6,330 |
) |
|
Provision for income taxes |
|
37 |
|
|
|
41 |
|
|
Net loss and comprehensive loss |
|
(2,363 |
) |
|
|
(6,371 |
) |
|
Loss attributable to noncontrolling interest |
|
96 |
|
|
1,145 |
|
|
|
Net loss attributable to |
$ |
(2,267 |
) |
|
$ |
(5,226 |
) |
|
|
|
|
|
|
|
|
|
|
Net loss per share attributable to common stockholders |
|
|
|
|
|
|
|
|
Basic |
$ |
(0.03 |
) |
|
$ |
(0.08 |
) |
|
Diluted |
$ |
(0.03 |
) |
|
$ |
(0.08 |
) |
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding |
|
|
|
|
|
|
|
|
Basic |
|
68,205,614 |
|
|
|
62,950,895 |
|
|
Diluted |
|
68,205,614 |
|
|
76,496,102 |
|
|
|
|
|||||||
|
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) |
|||||||
|
(in thousands) |
|||||||
|
|
|
|
|
|
|
||
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
$ |
26,594 |
|
|
$ |
25,354 |
|
|
Accounts receivable, net |
|
9,072 |
|
|
|
11,106 |
|
|
Inventories |
|
15,232 |
|
|
|
20,393 |
|
|
Prepaid expenses and other current assets |
|
1,772 |
|
|
|
1,367 |
|
|
Total current assets |
|
52,670 |
|
|
|
58,220 |
|
|
Property and equipment, net |
|
894 |
|
|
|
867 |
|
|
Right-of-use assets under operating leases, net |
|
412 |
|
|
|
549 |
|
|
Intangible assets, net |
|
3,120 |
|
|
|
3,135 |
|
|
Other non-current assets |
|
830 |
|
|
|
849 |
|
|
Total assets |
$ |
57,926 |
|
|
$ |
63,620 |
|
|
LIABILITIES AND EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
14,248 |
|
|
$ |
17,565 |
|
|
Accrued expenses and other current liabilities |
|
9,055 |
|
|
|
9,786 |
|
|
Current portion of operating lease liabilities |
|
490 |
|
|
|
668 |
|
|
Total current liabilities |
|
23,793 |
|
|
|
28,019 |
|
|
Total liabilities |
|
23,793 |
|
|
|
28,019 |
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ equity |
|
|
|
|
|
|
|
|
Class A common stock |
|
70 |
|
|
|
67 |
|
|
Class B common stock |
|
6 |
|
|
|
8 |
|
|
Additional paid-in capital |
|
178,312 |
|
|
|
182,226 |
|
|
Accumulated deficit |
|
(133,529 |
) |
|
|
(131,262 |
) |
|
Total |
|
44,859 |
|
|
|
51,039 |
|
|
Noncontrolling interests |
|
(10,726 |
) |
|
|
(15,438 |
) |
|
Total equity |
|
34,133 |
|
|
|
35,601 |
|
|
Total liabilities and equity |
$ |
57,926 |
|
|
$ |
63,620 |
|
|
|
|||||||
|
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) |
|||||||
|
(in thousands) |
|||||||
|
|
Three Months Ended |
|
|||||
|
|
2026 |
|
|
2025 |
|
||
|
Operating activities: |
|
|
|
|
|
|
|
|
Net loss |
$ |
(2,363 |
) |
|
$ |
(6,371 |
) |
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
|
|
|
|
|
|
|
|
Non-cash lease expense |
|
137 |
|
|
|
138 |
|
|
Depreciation and amortization |
|
168 |
|
|
|
252 |
|
|
Loss on disposal of property, equipment and software, net |
|
— |
|
|
|
4 |
|
|
Amortization of debt issuance cost |
|
19 |
|
|
|
19 |
|
|
Equity-based compensation |
|
894 |
|
|
|
731 |
|
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable, net |
|
2,034 |
|
|
|
1,998 |
|
|
Inventories |
|
5,161 |
|
|
|
1,513 |
|
|
Prepaid expenses and other assets |
|
(405 |
) |
|
|
(872 |
) |
|
Accounts payable |
|
(3,095 |
) |
|
|
(1,419 |
) |
|
Accrued expenses and other current liabilities |
|
(731 |
) |
|
|
1,149 |
|
|
Operating lease liabilities |
|
(178 |
) |
|
|
(67 |
) |
|
Net cash provided by (used in) operating activities |
|
1,641 |
|
|
|
(2,925 |
) |
|
Investing activities: |
|
|
|
|
|
|
|
|
Purchases of property, equipment and software |
|
(270 |
) |
|
|
(11 |
) |
|
Net cash used in investing activities |
|
(270 |
) |
|
|
(11 |
) |
|
Financing activities: |
|
|
|
|
|
|
|
|
Proceeds from exercise of stock options |
|
1 |
|
|
|
— |
|
|
Financing costs paid |
|
(132 |
) |
|
|
— |
|
|
Net cash used in financing activities |
|
(131 |
) |
|
|
— |
|
|
Net change from operating, investing, and financing activities |
|
1,240 |
|
|
|
(2,936 |
) |
|
Cash and cash equivalents at beginning of period |
|
25,354 |
|
|
|
30,653 |
|
|
Cash and cash equivalents at end of period |
$ |
26,594 |
|
|
$ |
27,717 |
|
Use of Non-GAAP Financial Information
We use Adjusted Net Loss and Adjusted EBITDA, financial measures that are not calculated in accordance with
We calculate Adjusted Net Loss as net loss adjusted to exclude: (1) restructuring expenses, and (2) certain litigation expenses.
We calculate Adjusted EBITDA as net loss adjusted to exclude: (1) other income (expense), net, which includes interest (income) expense and foreign currency (gains) losses, (2) (benefit) provision for income taxes, (3) depreciation and amortization, (4) equity-based compensation, (5) restructuring expenses, and (6) certain litigation expenses. Also, Adjusted EBITDA may in the future be adjusted for amounts impacting net income related to the Tax Receivable Agreement liability and other infrequent and unusual transactions.
Adjusted Net Loss and Adjusted EBITDA are presented for supplemental informational purposes only, have limitations as analytical tools and should not be considered in isolation or as a substitute for financial information presented in accordance with
In addition, our use of Adjusted Net Loss and Adjusted EBITDA may not be comparable to similarly-titled measures of other companies because they may not calculate Adjusted Net Loss and Adjusted EBITDA in the same manner, limiting their usefulness as comparative measures. Because of these limitations, when evaluating our performance, you should consider Adjusted Net Loss and Adjusted EBITDA alongside other financial measures, including our net income (loss) and other results stated in accordance with
|
|
|||||||
|
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL RESULTS |
|||||||
|
(in thousands) |
|||||||
|
(unaudited) |
|||||||
|
|
|||||||
|
The following table presents a reconciliation of net loss, the most directly comparable financial measure stated in accordance with GAAP, to Adjusted Net Loss for the periods presented: |
|||||||
|
|
Three Months Ended |
|
|||||
|
(in thousands) |
2026 |
|
|
2025 |
|
||
|
Net loss and comprehensive loss |
$ |
(2,363 |
) |
|
$ |
(6,371 |
) |
|
Restructuring |
|
— |
|
|
|
2,138 |
|
|
Certain litigation expenses |
|
2,250 |
|
|
|
— |
|
|
Adjusted Net Loss |
$ |
(113 |
) |
|
$ |
(4,233 |
) |
| The following table presents a reconciliation of net loss, the most directly comparable financial measure stated in accordance with GAAP, to Adjusted EBITDA for the periods presented: | |||||||
|
|
Three Months Ended |
|
|||||
|
(in thousands) |
2026 |
|
|
2025 |
|
||
|
Net loss and comprehensive loss |
$ |
(2,363 |
) |
|
$ |
(6,371 |
) |
|
Other income, net* |
|
(47 |
) |
|
|
(57 |
) |
|
Provision for income taxes |
|
37 |
|
|
|
41 |
|
|
Depreciation and amortization |
|
168 |
|
|
|
252 |
|
|
Equity-based compensation |
|
894 |
|
|
|
731 |
|
|
Restructuring |
|
— |
|
|
|
2,138 |
|
|
Certain litigation expenses |
|
2,250 |
|
|
|
— |
|
|
Adjusted EBITDA |
$ |
939 |
|
|
$ |
(3,266 |
) |
|
* Includes interest (income) expense, and foreign currency (gains) losses. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260506805200/en/
Investors
ADDO Investor Relations
zevia@addo.com
Source: